Ducommun (DCO) has just posted another quarterly update, with Q4 2025 revenue at US$215.9 million and basic EPS of US$0.27 on net income of US$4.0 million. This sets the stage for how investors will read the company’s 2026 outlook. Over recent quarters, the company has seen revenue move from US$197.2 million in Q4 2024 to US$215.9 million in Q4 2025, while basic EPS has ranged from a loss of US$0.21 in Q4 2024 to a loss of US$4.30 in Q3 2025, before returning to US$0.27 in Q4 2025. With margins still under pressure on a trailing 12 month basis, this latest print gives investors a fresh data point on whether the path toward more stable profitability is taking shape.

See our full analysis for Ducommun.

With the headline numbers on the table, the next step is to see how they compare with the widely followed narratives around Ducommun’s growth potential, risk profile, and path back to consistent margins.

Revenue Near US$825 million, Profit Still Under Pressure

• On a trailing 12 month basis, Ducommun booked about US$824.8 million in revenue while reporting a net loss of US$37.4 million and basic EPS of US$2.50 in loss terms.
• Analysts' consensus view points to a very different earnings path from what the trailing numbers show, with revenue forecast to grow about 7.8% per year and earnings modeled to move from a loss of US$33.9 million to US$90.8 million by around 2029.
  • That projected shift to an 8.9% profit margin contrasts with the recent loss, so anyone leaning on the consensus case needs to be comfortable that the current pressure on margins can improve from the trailing 12 month level.
  • The consensus also assumes Ducommun reaches roughly US$1.0b of revenue, compared with the current trailing US$824.8 million, which is a step up but not a straight-line continuation of the recent quarterly pattern.

Q3 2025 Loss Weighs On Recent Track Record

• Within the last year, Q3 2025 stands out with revenue of US$212.6 million and a net loss of US$64.4 million, far larger than the US$3.0 million loss in Q4 2024 and the US$4.0 million profit in Q4 2025.
• Critics highlight this period as backing the bearish concern about execution risk and earnings volatility, especially around facility consolidation and production transitions.
  • The shift from profits of US$10.5 million and US$12.6 million in Q1 and Q2 2025 to the much deeper loss in Q3 2025 fits with worries that moving work to new locations or recertifying product lines can create cost spikes or disruption.
  • The fact that Q4 2025 returned to a profit of US$4.0 million does not erase that earlier loss, so bearish investors may focus on how quickly or consistently those operational issues can be contained.

Stay on top of how the cautious case stacks up against each new set of results with the full bearish narrative 🐻 Ducommun Bear Case

Low P/S Multiple Versus Peers

• Ducommun trades on a P/S of 2.7x, compared with 5.1x for peers and 5.2x for the wider US Aerospace & Defense group. A DCF fair value of US$192.12 sits above both the current share price of US$145.03 and the analyst target of US$146.60.
• Supporters of the bullish narrative point to this valuation gap alongside the earnings rebound story, arguing that current pricing does not fully reflect the forecasts.
  • The DCF fair value implies a sizeable gap to the market price, and analysts are also building in earnings per share of US$5.62 by around 2029, which is a very different picture from the recent trailing loss.
  • At the same time, the stock already sits close to the US$146.60 analyst target, so anyone leaning bullish needs to decide whether the lower P/S and DCF fair value leave enough room based on their own expectations for revenue growth and margin progress.

If you want to see how the optimistic case ties these numbers together, take a look at the full bullish narrative 🐂 Ducommun Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Ducommun on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

The mix of cautious and optimistic signals around Ducommun will not stay unresolved forever, so move quickly to review the numbers yourself and weigh both sides with the help of 2 key rewards and 1 important warning sign

See What Else Is Out There

Recent results still show pressure on profitability, with a trailing net loss of US$37.4 million and a sharp Q3 2025 setback weighing on consistency.

If that earnings volatility makes you cautious, it is worth quickly checking a list of 69 resilient stocks with low risk scores to compare steadier options that better match your comfort level.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.